Internal Server Error

Arunabio - About the company

Arunabio is a series B company based in Athens (United States), founded in 2003. It operates as a Developer of a neural exosome platform to design therapeutics for the treatment of neurodegenerative diseases. Arunabio has raised $33.1M in funding from Eshelman Ventures. The company has 213 active competitors, including 35 funded and 32 that have exited. Its top competitors include companies like BioLife Solutions, Integrated DNA Technologies and RoosterBio.

Company Details

Developer of a neural exosome platform to design therapeutics for the treatment of neurodegenerative diseases. The platform develops neural exosomes to cross the blood-brain barrier and enhance the body's anti-inflammatory, self-repair, and protective mechanisms to treat a range of neurodegenerative disorders. The lead candidate drug AB126 is developed to treat stroke, Parkinson's, and multiple sclerosis
Social
X
Phone Number
+1 **********
Key Metrics
Founded Year
2003
Location
Athens, United States
Stage
Series B
Total Funding
$33.1M in 21 rounds
Ranked
Employee Count
27 as on Aug 31, 2026
Similar Companies
Sign up to download Arunabio's company profile

Arunabio's funding and investors

Arunabio has raised a total funding of $33.1M over 21 rounds. Its latest funding round was a Grant (prize money) round on Aug 07, 2025 for $*****. 1 investor participated in its latest round. Arunabio has 8 institutional investors.

Here is the list of recent funding rounds of Arunabio:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Aug 07, 2025
4295909
Grant (prize money)
9376538
5851218
5767024
8007486
Jun 01, 2022
3046275
Grant (prize money)
4502573
1942184
4098790
Apr 14, 2021
5477107
Series B
4256966
3456870
2197453
6072302
lockAccess funding benchmarks and valuations. Sign up today!

Arunabio's founders and board of directors

Founder? Claim Profile

Arunabio's employee count trend

Arunabio has 27 employees as of Aug 26. Here is Arunabio's employee count trend over the years:
Employee count trend for Arunabio
lockUncover Arunabio's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Arunabio's Competitors and alternates

Top competitors of Arunabio include BioLife Solutions, Integrated DNA Technologies and RoosterBio. Here is the list of Top 10 competitors of Arunabio, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for BioLife Solutions
BioLife Solutions
1987, Bothell (United States), Acquired
Developer of cell and gene therapies with the integrity of a single cell
-
-
67/100
2nd
Logo for Integrated DNA Technologies
Integrated DNA Technologies
1987, Coralville (United States), Acquired
Provider of oligonucleotide-based reagents and kits
-
63/100
3rd
Logo for RoosterBio
RoosterBio
2012, Frederick (United States), Series B
Developer of human mesenchymal stem cells and extracellular vesicles
$38.4M
57/100
4th
Logo for BioLamina
BioLamina
2008, Sundbyberg (Sweden), Series B
Cell culture reagents for stem cell research
$18.2M
56/100
5th
Logo for Evox Therapeutics
Evox Therapeutics
2016, Oxford (United Kingdom), Series C
Developer of exosome-based therapeutics for severe neurological and rare diseases
$156M
53/100
6th
Logo for Shanghai Doning Biotechnology
Shanghai Doning Biotechnology
2005, Shanghai (China), Series C
Provider of cell culture media
$14.9M
53/100
7th
Logo for ArcticZymes
ArcticZymes
2009, Tromso (Norway), Public
Developer of recombinant enzymes from various arctic species
-
49/100
8th
Logo for Ribometrix
Ribometrix
2016, Raleigh (United States), Series A
Provider RNA-targeted drug discovery platform
$65.3M
49/100
9th
Logo for Toyobo
Toyobo
1882, New York City (United States), Public
Manufacturer of high performance materials including films and functional textiles
-
-
49/100
10th
Logo for Multus
Multus
2019, London (United Kingdom), Series A
Provider of lab-grown meat alternatives
$9.3M
45/100
15th
Logo for Arunabio
Arunabio
2003, Athens (United States), Series B
Developer of a neural exosome platform to design therapeutics for the treatment of neurodegenerative diseases
$33.1M
44/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Arunabio's competitors? Click here to see the top ones

Arunabio's Investments and acquisitions

Arunabio has made no investments or acquisitions yet.

Reports related to Arunabio

Here is the latest report on Arunabio's sector:

News related to Arunabio

lockFilter this list
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Arunabio

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford